These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26819233)

  • 1. Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia.
    Strilka RJ; Stull MC; Clemens MS; McCaver SC; Armen SB
    Theor Biol Med Model; 2016 Jan; 13():3. PubMed ID: 26819233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative analysis of subcutaneous Lispro and regular insulin injections for stress hyperglycemia: a pilot numerical study.
    Strilka RJ; Armen SB; Indeck MC
    J Theor Biol; 2014 Sep; 356():192-200. PubMed ID: 24769252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study.
    Stull MC; Strilka RJ; Clemens MS; Armen SB
    J Diabetes Sci Technol; 2015 Jun; 10(1):137-44. PubMed ID: 26134836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
    Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
    Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
    Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
    Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
    Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
    Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Basal Plus Versus Sliding Scale Insulin Therapy on Glucose Variability in Critically Ill Patients Without Preexisting Diabetes.
    Webster RE; Belfer JJ; Schmidt KJ
    Ann Pharmacother; 2024 Jun; 58(6):565-571. PubMed ID: 37700565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to evaluate the effectiveness of glargine and multiple injections of lispro in patients with type 2 diabetes receiving tube feedings in a cardiovascular intensive care unit.
    Grainger A; Eiden K; Kemper J; Reeds D
    Nutr Clin Pract; 2007 Oct; 22(5):545-52. PubMed ID: 17906278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of blood glucose during enteral nutrition in critical patients].
    Liu Y; He W; Zhou H; Li T; Xu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Sep; 24(9):546-9. PubMed ID: 22938664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia management in the hospital setting.
    Hassan E
    Am J Health Syst Pharm; 2007 May; 64(10 Suppl 6):S9-S14. PubMed ID: 17494893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.